Treatment of Established Relapsing Experimental Autoimmune Encephalomyelitis with the Proteasome Inhibitor PS-5191

This publication has 37 references indexed in Scilit:

• Proteasome inhibition: A novel mechanism to combat asthma☆☆☆
  Journal of Allergy and Clinical Immunology, 1999
• Cardioprotective Effects of a Novel Proteasome Inhibitor Following Ischemia and Reperfusion in the Isolated Perfused Rat Heart
  Journal of Molecular and Cellular Cardiology, 1999
• Mediation by NF-κB of cytokine induced expression of intercellular adhesion molecule 1 (ICAM-1) in an intestinal epithelial cell line, a process blocked by proteasome inhibitors
  Gut, 1998
• Nuclear Factor (NF)-κB2 (p100/p52) Is Required for Normal Splenic Microarchitecture and B Cell–mediated Immune Responses
  The Journal of Experimental Medicine, 1998
• Expression and Regulation of Cyclooxygenase‐2 in Rat Microglia
  European Journal of Biochemistry, 1997
• THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
  Annual Review of Immunology, 1996
• New insights into proteasome function: from archaebacteria to drug development
  Chemistry & Biology, 1995
• T Cell Activation Pathways: B7, LFA-3, and ICAM-1 Shape Unique T Cell Profiles
  Critical Reviews in Immunology, 1995
• Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein
  Published by Elsevier ,1992
• A Multiubiquitin Chain Is Confined to Specific Lysine in a Targeted Short-Lived Protein
  Science, 1989